Diabetes, Dyslipidemia Screening Rates Low After Pregnancy, Even for Those With HTN, GDM
By Elana Gotkine HealthDay Reporter
FRIDAY, Feb. 21, 2025 -- Patients with pregnancy-related hypertension (HTN) or diabetes are more likely to be screened for diabetes and dyslipidemia after delivery, but screening rates remain low for those with and without HTN and diabetes, according to a research letter published online Feb. 17 in Circulation.
Amy Y.X. Yu, M.D., from the University of Toronto, and colleagues conducted a population-based cohort study and compared postpartum screening for diabetes and dyslipidemia among patients with and without hypertensive disorders of pregnancy or gestational diabetes (GDM). A total of 1,265,015 pregnant patients younger than 50 years who were discharged alive after admission for a live birth, stillbirth, or intentional pregnancy termination after ≥20 completed weeks of gestation were identified.
The researchers found 165,660 patients (13.1 percent) had pregnancy-related hypertension or diabetes, which was the main exposure. Among exposed patients, 81.1 percent had pregnancy-related hypertension or diabetes during the index pregnancy, and the rest were exposed during a previous pregnancy. Compared with unexposed patients, exposed patients were more likely to be screened for diabetes and dyslipidemia within three years, but the difference was moderate and both groups had low screening rates (43.8 versus 33.0 percent; relative risk [RR], 1.33). Screening within one year was also low (17.3 percent exposed versus 11.1 percent unexposed; RR, 1.56). Screening was lower for dyslipidemia within three years than for diabetes (RRs, 1.32 versus 1.19). During the 17-year study period, screening practices remained relatively similar.
"Suboptimal vascular risk factor screening after pregnancy-related hypertension or diabetes is a missed opportunity for cardiovascular prevention," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Biomarker Panel Improves Prediction of CKD Progression in Children
TUESDAY, June 24, 2025 -- A biomarker panel can improve prediction of chronic kidney disease (CKD) progression in children, according to a study published in the June issue of the...
Relative Peripheral Refraction Predicts Myopia Progression in Children
TUESDAY, June 24, 2025 -- Vertical and horizontal relative peripheral refraction (RPR) are associated with faster axial length progression and higher risk of incident myopia...
Hydrops MRI Accurately Differentiates Meniere Disease, Vestibular Migraine
MONDAY, June 23, 2025 -- The combination of cochlear endolymphatic hydrops (CEH) and vestibular endolymphatic hydrops (VEH) on magnetic resonance imaging (MRI) accurately...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.